1026586-38-8

Basic information

• Product Name: 4-Morpholinotetrahydro-2H-pyran-4-carbonitrile
• Synonyms: 4-Morpholinotetrahydro-2H-pyran-4-carbonitrile;4-(Morpholin-4-yl)oxane-4-carbonitrile;Tetrahydro-4-(4-morpholinyl)-2H-pyran-4-carbonitrile
• CAS NO: 1026586-38-8
• Molecular Formula: C10H16N2O2
• Molecular Weight: 196.24624
• Mol File: 1026586-38-8.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 4-Morpholinotetrahydro-2H-pyran-4-carbonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Morpholinotetrahydro-2H-pyran-4-carbonitrile(1026586-38-8)
• EPA Substance Registry System: 4-Morpholinotetrahydro-2H-pyran-4-carbonitrile(1026586-38-8)

Safety Data

• Hazardous Substances Data: 1026586-38-8(Hazardous Substances Data)

Usage

General Description

4-Morpholinotetrahydro-2H-pyran-4-carbonitrile is a chemical compound with the molecular formula C9H13N3O2. It is a heterocyclic compound containing a morpholine ring and a pyran ring, as well as a carbonitrile functional group. 4-Morpholinotetrahydro-2H-pyran-4-carbonitrile has demonstrated potential biological activity and has been studied as a potential pharmaceutical intermediate. Its chemical structure and properties make it a valuable building block for the synthesis of various drug molecules and other organic compounds. Research continues to investigate its potential applications in the pharmaceutical and chemical industries.

Upstream product

• 110-91-8 morpholine 
• 29943-42-8 Tetrahydro-4H-pyran-4-one 
• 75-86-5 2-hydroxy-2-methylpropanenitrile 

Relevant articles and documents

NOVEL BENZAMIDE DERIVATIVE AND USE THEREOF

Disclosed are a novel benzamide derivative and pharmaceutical use thereof, and more particularly, a novel benzamide derivative having a structure of Formula 1 or pharmaceutically acceptable salts thereof, and a composition for prevention or treatment of pain or itching including the above material. The novel benzamide derivative and pharmaceutically acceptable salt thereof according to the present invention exhibit excellent pain-suppressive effect and, in particular, pain-suppressive effect in not only a neuropathic animal model but also other models such as a formalin model, and therefore, may be used in suppression of different pains such as nociceptive pain, chronic pain, etc. Further, since it was demonstrated that the present invention displays anti-pruritic efficacy even in an itching model, to which a mechanism and treatment concept established with respect to pain is applied, the present invention may also be effectively used in radical treatment of atopic dermatitis by applying the inventive product to an anti-pruritic composition in order to suppress an initial itching stage and treat symptoms thereof, thus preventing skin damage or inflammation after the scratching stage.

INDAZOLE COMPOUNDS AS KINASE INHIBITORS AND METHOD OF TREATING CANCER WITH SAME

The present teaching provide indazole compounds represented by Structural Formulae (I) or (I') or a pharmaceutically acceptable salt thereof. Also described are pharmaceutical compositions and methods of use thereof as protein kinase inhibitors, such as T